Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Nisreen Murad"'
Autor:
Yaseen M. Arabi, Ayed Y. Asiri, Abdullah M. Assiri, Mashan L. Abdullah, Haya A. Aljami, Hanan H. Balkhy, Majed Al Jeraisy, Yasser Mandourah, Sameera AlJohani, Shmeylan Al Harbi, Hani A. Aziz Jokhdar, Ahmad M. Deeb, Ziad A. Memish, Jesna Jose, Sameeh Ghazal, Sarah Al Faraj, Ghaleb A. Al Mekhlafi, Nisreen Murad Sherbeeni, Fatehi Elnour Elzein, Frederick G. Hayden, Robert A. Fowler, Badriah M. AlMutairi, Abdulaziz Al-Dawood, Naif Khalaf Alharbi
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Animal and human data indicate variable effects of interferons in treating coronavirus infections according to inflammatory status and timing of therapy. In this sub-study of the MIRACLE trial (MERS-CoV Infection Treated with a Combination o
Externí odkaz:
https://doaj.org/article/e5a94615be554d5c80e9bfc21370cdd0
Autor:
Yaseen M. Arabi, Ayed Y. Asiri, Abdullah M. Assiri, Hani A. Aziz Jokhdar, Adel Alothman, Hanan H. Balkhy, Sameera AlJohani, Shmeylan Al Harbi, Suleiman Kojan, Majed Al Jeraisy, Ahmad M. Deeb, Ziad A. Memish, Sameeh Ghazal, Sarah Al Faraj, Fahad Al-Hameed, Asim AlSaedi, Yasser Mandourah, Ghaleb A. Al Mekhlafi, Nisreen Murad Sherbeeni, Fatehi Elnour Elzein, Abdullah Almotairi, Ali Al Bshabshe, Ayman Kharaba, Jesna Jose, Abdulrahman Al Harthy, Mohammed Al Sulaiman, Ahmed Mady, Robert A. Fowler, Frederick G. Hayden, Abdulaziz Al-Dawood, Mohamed Abdelzaher, Wail Bajhmom, Mohamed A. Hussein, and the Saudi Critical Care Trials group
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-8 (2020)
Abstract The MIRACLE trial (MERS-CoV Infection tReated with A Combination of Lopinavir/ritonavir and intErferon-β1b) investigates the efficacy of a combination therapy of lopinavir/ritonavir and recombinant interferon-β1b provided with standard sup
Externí odkaz:
https://doaj.org/article/98b352d6164e45ae9eb5230477b9fe36
Autor:
Yaseen M. Arabi, Adel Alothman, Hanan H. Balkhy, Abdulaziz Al-Dawood, Sameera AlJohani, Shmeylan Al Harbi, Suleiman Kojan, Majed Al Jeraisy, Ahmad M. Deeb, Abdullah M. Assiri, Fahad Al-Hameed, Asim AlSaedi, Yasser Mandourah, Ghaleb A. Almekhlafi, Nisreen Murad Sherbeeni, Fatehi Elnour Elzein, Javed Memon, Yusri Taha, Abdullah Almotairi, Khalid A. Maghrabi, Ismael Qushmaq, Ali Al Bshabshe, Ayman Kharaba, Sarah Shalhoub, Jesna Jose, Robert A. Fowler, Frederick G. Hayden, Mohamed A. Hussein, And the MIRACLE trial group
Publikováno v:
Trials, Vol 19, Iss 1, Pp 1-13 (2018)
Abstract Background It had been more than 5 years since the first case of Middle East Respiratory Syndrome coronavirus infection (MERS-CoV) was recorded, but no specific treatment has been investigated in randomized clinical trials. Results from in v
Externí odkaz:
https://doaj.org/article/e2349ce186d145d0a4893a860406c946
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
null Faizah Alotaibi, null Naif Khalaf Alharbi, null Lindsey B. Rosen, null Ayed Y. Asiri, null Abdullah M. Assiri, null Hanan H. Balkhy, null Majed Al Jeraisy, null Yasser Mandourah, null Sameera AlJohani, null Shmeylan Al Harbi, null Hani A. Aziz Jokhdar, null Ahmad M. Deeb, null Ziad A. Memish, null Jesna Jose, null Sameeh Ghazal, null Sarah Al Faraj, null Ghaleb A. Al Mekhlafi, null Nisreen Murad Sherbeeni, null Fatehi Elnour Elzein, null Badriah M. AlMutairi, null Abdulaziz Al‐Dawood, null Mashan L. Abdullah, null Tlili Barhoumi, null Mohammed W. Alenazi, null Abdulrahman Almasood, null Steven M. Holland, null Yaseen M. Arabi, null the Saudi Critical Care Trials Group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee16a1656f989e6e9eef742a95868103
https://doi.org/10.1111/irv.13116/v2/response1
https://doi.org/10.1111/irv.13116/v2/response1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Arabi, Yaseen M., Asiri, Ayed Y., Assiri, Abdullah M., Abdullah, Mashan L., Aljami, Haya A., Balkhy, Hanan H., Al Jeraisy, Majed, Mandourah, Yasser, AlJohani, Sameera, Al Harbi, Shmeylan, Jokhdar, Hani A. Aziz, Deeb, Ahmad M., Memish, Ziad A., Jose, Jesna, Ghazal, Sameeh, Al Faraj, Sarah, Al Mekhlafi, Ghaleb A., Sherbeeni, Nisreen Murad, Elzein, Fatehi Elnour, Hayden, Frederick G.
Publikováno v:
Scientific Reports; 10/28/2022, Vol. 12 Issue 1, p1-10, 10p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hani Jokhdar, Majed Al Jeraisy, Jesna Jose, Mohamed A. Hussein, Fahad Al-Hameed, Mohamed Abdelzaher, Ahmed Mady, Sarah Al Faraj, Frederick G. Hayden, Ayed Y. Asiri, Nisreen Murad Sherbeeni, Suleiman Kojan, Wail Bajhmom, Hanan H. Balkhy, Robert A. Fowler, Abdulrahman Al Harthy, Abdullah M. Assiri, Abdullah Almotairi, Shmeylan Al Harbi, Mohammed Al Sulaiman, Yasser Mandourah, Sameera Aljohani, Asim Alsaedi, Fatehi Elzein, Ahmad M. Deeb, Ayman Kharaba, Yaseen M. Arabi, Adel Alothman, Ghaleb A. Al Mekhlafi, Ziad A. Memish, Ali Al Bshabshe, Abdulaziz Al-Dawood, Sameeh S. Ghazal
Publikováno v:
Trials
Trials, Vol 21, Iss 1, Pp 1-8 (2020)
Trials, Vol 21, Iss 1, Pp 1-8 (2020)
Abstract The MIRACLE trial (MERS-CoV Infection tReated with A Combination of Lopinavir/ritonavir and intErferon-β1b) investigates the efficacy of a combination therapy of lopinavir/ritonavir and recombinant interferon-β1b provided with standard sup
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d0df3a786a55ef8b32a1cd2d31c3fec
https://pubmed.ncbi.nlm.nih.gov/31900204
https://pubmed.ncbi.nlm.nih.gov/31900204
Publikováno v:
Infection Control & Hospital Epidemiology. 41:s266-s266
Background: The current NHSN guideline states that positive results from both blood cultures and non–culture-based testing (NCT) methodologies are to be used for central-line–associated bloodstream infection (CLABSI) surveillance determination. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1792e3ae8edea8a2607607bb34cc6f1a
https://doi.org/10.1017/ice.2020.834
https://doi.org/10.1017/ice.2020.834